1. Home
  2. T vs NVO Comparison

T vs NVO Comparison

Compare T & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AT&T Inc.

T

AT&T Inc.

HOLD

Current Price

$28.32

Market Cap

166.5B

ML Signal

HOLD

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$36.56

Market Cap

172.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
T
NVO
Founded
1983
1923
Country
United States
Denmark
Employees
N/A
69500
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
166.5B
172.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
T
NVO
Price
$28.32
$36.56
Analyst Decision
Buy
Hold
Analyst Count
20
11
Target Price
$30.87
$51.00
AVG Volume (30 Days)
32.8M
14.8M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
3.83%
3.61%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.40
N/A
Revenue Next Year
$2.14
$3.30
P/E Ratio
$9.14
$13.60
Revenue Growth
N/A
N/A
52 Week Low
$22.95
$35.12
52 Week High
$29.79
$81.44

Technical Indicators

Market Signals
Indicator
T
NVO
Relative Strength Index (RSI) 51.39 36.98
Support Level $28.21 $35.85
Resistance Level $28.35 $39.58
Average True Range (ATR) 0.59 0.92
MACD -0.01 0.39
Stochastic Oscillator 46.95 34.82

Price Performance

Historical Comparison
T
NVO

About T AT&T Inc.

The wireless business contributes nearly 70% of AT&T's revenue. The company is the third-largest US wireless carrier, connecting 74 million postpaid and 17 million prepaid phone customers. Fixed-line enterprise services, which account for about 14% of revenue, include internet access, private networking, security, voice, and wholesale network capacity. Residential fixed-line services, about 12% of revenue, primarily consist of broadband internet access, serving 15 million customers. AT&T also has a sizable presence in Mexico, with 24 million customers, but this business only accounts for 3% of revenue. The company recently sold its 70% equity stake in satellite television provider DirecTV to its partner, private equity firm TPG.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: